0001214659-12-000632.txt : 20120214
0001214659-12-000632.hdr.sgml : 20120214
20120214140822
ACCESSION NUMBER: 0001214659-12-000632
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111231
FILED AS OF DATE: 20120214
DATE AS OF CHANGE: 20120214
EFFECTIVENESS DATE: 20120214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: TANG CAPITAL MANAGEMENT LLC
CENTRAL INDEX KEY: 0001232621
IRS NUMBER: 680517275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-14822
FILM NUMBER: 12607605
BUSINESS ADDRESS:
STREET 1: 4401 ESTGATE MALL
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582003830
MAIL ADDRESS:
STREET 1: 4401 EASTGATE MALL
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
13F-HR
1
c21412013fhr.txt
REPORT FOR THE CALENDAR YEAR ENDED DECEMBER 31, 2011
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
FORM 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: December 31, 2011
Check here if Amendment [ ]; Amendment Number: __
This Amendment (Check only one): [ ] is a restatement.
[ ] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Tang Capital Management, LLC
Address: 4747 Executive Drive, Suite 510, San Diego, CA 92121
Form 13F File Number:
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Kevin C. Tang
Title: Managing Director of Tang Capital Management, LLC
Phone: 858-200-3830
Signature, Place, and Date of Signing:
/s/ Kevin C. Tang San Diego, CA February 14, 2012
----------------------- ------------------------ -------------------------
[Signature] [City, State] [Date]
Report Type (Check only one.):
[X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager
are reported in this report.)
[_] 13F NOTICE. (Check here if no holdings reported are in this report, and all
holdings are reported by other reporting manager(s).)
[_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this
reporting manager are reported in this report and a portion are reported by
other reporting manager(s).)
List of Other Managers Reporting for this Manager: NONE
FORM 13F SUMMARY PAGE
REPORT SUMMARY:
NUMBER OF OTHER INCLUDED MANAGERS: 1
FORM 13F INFORMATION TABLE ENTRY TOTAL: 29
FORM 13F INFORMATION TABLE VALUE TOTAL: 356,107
(thousands)
LIST OF OTHER INCLUDED MANAGERS:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
1 Kevin C. Tang 028-14818
FORM 13F INFORMATION TABLE
VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE
ACHILLION PHARMACEUTICALS INC COM 00448Q201 7,138 936,800 SH SOLE 936,800 0 0
AFFYMETRIX INC NOTE 3.500% 1/15/38 00826TAG3 70,769 70,829,000 PRN SOLE 70,829,000 0 0
AFFYMETRIX INC NOTE 3.500% 1/15/38 00826TAG3 520 520,000 PRN SHARED- 1 204,000 214,000 102,000
DEFINED
ARDEA BIOSCIENCES INC COM 03969P107 55,593 3,307,112 SH SOLE 3,307,112 0 0
ARDEA BIOSCIENCES INC COM 03969P107 3,499 208,177 SH SHARED- 1 82,141 114,036 12,000
DEFINED
AVANIR PHARMACEUTICALS INC COM 05348P401 3,198 1,560,223 SH SOLE 1,560,223 0 0
BIOMARIN PHARMACEUTICALS INC NOTE 2.500% 3/29/13 09061GAC5 6,296 3,000,000 PRN SOLE 3,000,000 0 0
CADENCE PHARMACEUTICALS INC COM 12738T100 1,943 491,953 SH SOLE 491,953 0 0
CYCLACEL PHARMACEUTICALS INC PFD CONV EX 6% 23254L207 792 277,993 SH SOLE 277,993 0 0
DENDREON CORP COM 24823Q107 605 79,600 SH SHARED- 1 0 79,600 0
DEFINED
DENDREON CORP NOTE 4.750% 6/15/14 24823QAB3 3,560 4,000,000 PRN SOLE 4,000,000 0 0
DENDREON CORP NOTE 2.875% 1/15/16 24823QAC1 6,847 9,815,000 PRN SOLE 9,815,000 0 0
DEPOMED INC COM 249908104 14,339 2,768,145 SH SOLE 2,768,145 0 0
ENDOCYTE INC COM 29269A102 1,751 465,763 SH SOLE 465,763 0 0
INTERMUNE INC NOTE 2.500% 9/15/18 45884XAE3 12,495 17,000,000 PRN SOLE 17,000,000 0 0
MANNKIND CORP COM 56400P201 82 32,888 SH SOLE 32,888 0 0
MANNKIND CORP NOTE 3.750% 12/15/13 56400PAA0 11,832 22,325,000 PRN SOLE 22,325,000 0 0
MANNKIND CORP PUT 56400P951 3,419 12,389 PUT SOLE 12,389 0 0
NEKTAR THERAPEUTICS INC NOTE 3.250% 9/28/12 640268AH1 68,334 69,907,000 PRN SOLE 69,907,000 0 0
NEOPROBE CORP COM 640518106 647 246,984 SH SOLE 246,984 0 0
OPKO HEALTH INC COM 68375N103 490 100,000 SH SOLE 100,000 0 0
OPTIMER PHARMACEUTICALS INC COM 68401H104 12,916 1,055,205 SH SOLE 1,055,205 0 0
PDL BIOPHARMA INC NOTE 2.875% 2/15/15 69329YAA2 39,509 37,474,000 PRN SOLE 37,474,000 0 0
SALIX PHARMACEUTICALS INC NOTE 5.500% 8/15/28 795435AB2 15,510 3,000,000 PRN SOLE 3,000,000 0 0
SAVIENT PHARMACEUTICALS COM 80517Q100 1,755 787,200 SH SOLE 787,200 0 0
SAVIENT PHARMACEUTICALS INC NOTE 4.750% 1/31/18 80517QAA8 4,300 10,000,000 PRN SOLE 10,000,000 0 0
SOMAXON PHARMACEUTICALS INC COM 834453102 504 1,119,602 SH SOLE 1,119,602 0 0
UNITED THERAPEUTICS CORP COM 91307C102 4,725 100,000 SH SOLE 100,000 0 0
VIROPHARMA INC COM 928241108 2,739 100,000 SH SOLE 100,000 0 0